A detailed history of Carlson Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Carlson Capital Management holds 2,449 shares of LLY stock, worth $1.85 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,449
Previous 2,391 2.43%
Holding current value
$1.85 Million
Previous $2.16 Million 0.23%
% of portfolio
0.15%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $44,784 - $55,681
58 Added 2.43%
2,449 $2.17 Million
Q2 2024

Jul 11, 2024

BUY
$724.87 - $909.04 $3,624 - $4,545
5 Added 0.21%
2,391 $2.16 Million
Q1 2024

Apr 12, 2024

SELL
$592.2 - $792.28 $138,574 - $185,393
-234 Reduced 8.93%
2,386 $1.86 Million
Q4 2023

Jan 16, 2024

SELL
$525.19 - $619.13 $17,331 - $20,431
-33 Reduced 1.24%
2,620 $1.53 Million
Q3 2023

Nov 21, 2023

BUY
$434.7 - $599.3 $1,738 - $2,397
4 Added 0.15%
2,653 $1.43 Million
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $347,934 - $465,228
-992 Reduced 27.25%
2,649 $1.24 Million
Q1 2023

Apr 17, 2023

BUY
$310.63 - $364.82 $2,174 - $2,553
7 Added 0.19%
3,641 $1.25 Million
Q4 2022

Feb 03, 2023

SELL
$321.55 - $374.67 $643 - $749
-2 Reduced 0.06%
3,634 $1.33 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $29,351 - $33,449
99 Added 2.8%
3,636 $1.18 Million
Q2 2022

Jul 18, 2022

SELL
$278.73 - $327.27 $140,479 - $164,944
-504 Reduced 12.47%
3,537 $1.15 Million
Q1 2022

May 24, 2022

BUY
$234.69 - $291.66 $4,693 - $5,833
20 Added 0.5%
4,041 $1.16 Million
Q4 2021

Jan 14, 2022

BUY
$224.85 - $279.04 $7,644 - $9,487
34 Added 0.85%
4,021 $1.11 Million
Q3 2021

Oct 12, 2021

BUY
$221.6 - $272.71 $1,551 - $1,908
7 Added 0.18%
3,987 $921,000
Q2 2021

Jul 12, 2021

BUY
$180.55 - $233.54 $5,055 - $6,539
28 Added 0.71%
3,980 $913,000
Q1 2021

Apr 12, 2021

BUY
$164.32 - $212.72 $13,638 - $17,655
83 Added 2.15%
3,952 $738,000
Q4 2020

Jan 11, 2021

BUY
$130.46 - $172.63 $3,000 - $3,970
23 Added 0.6%
3,869 $644,000
Q3 2020

Oct 13, 2020

BUY
$146.22 - $169.13 $1,315 - $1,522
9 Added 0.23%
3,846 $569,000
Q2 2020

Jul 13, 2020

BUY
$136.42 - $164.18 $14,869 - $17,895
109 Added 2.92%
3,837 $627,000
Q1 2020

Apr 27, 2020

SELL
$119.05 - $147.35 $14,881 - $18,418
-125 Reduced 3.24%
3,728 $607,000
Q4 2019

Jan 27, 2020

BUY
$106.92 - $132.43 $2,779 - $3,443
26 Added 0.68%
3,853 $506,000
Q3 2019

Oct 29, 2019

BUY
$106.79 - $116.16 $3,524 - $3,833
33 Added 0.87%
3,827 $428,000
Q2 2019

Jul 15, 2019

SELL
$110.79 - $129.32 $5,317 - $6,207
-48 Reduced 1.25%
3,794 $420,000
Q1 2019

Apr 25, 2019

SELL
$111.31 - $131.02 $174,200 - $205,046
-1,565 Reduced 28.94%
3,842 $499,000
Q4 2018

Jan 22, 2019

SELL
$105.9 - $118.64 $125,067 - $140,113
-1,181 Reduced 17.93%
5,407 $626,000
Q3 2018

Oct 19, 2018

SELL
$85.86 - $107.31 $6,782 - $8,477
-79 Reduced 1.18%
6,588 $707,000
Q2 2018

Jul 26, 2018

BUY
$75.7 - $86.88 $1,968 - $2,258
26 Added 0.39%
6,667 $569,000
Q1 2018

Apr 20, 2018

SELL
$74.21 - $87.6 $11,873 - $14,016
-160 Reduced 2.35%
6,641 $514,000
Q4 2017

Jan 08, 2018

BUY
$81.94 - $87.89 $7,538 - $8,085
92 Added 1.37%
6,801 $574,000
Q3 2017

Oct 16, 2017

BUY
$77.07 - $85.54 $517,062 - $573,887
6,709
6,709 $574,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Carlson Capital Management Portfolio

Follow Carlson Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Carlson Capital Management with notifications on news.